HCV elimination in active PWID: sofosbuvir/velpatasvir (SOF/VEL) as a simple tool to implement a test-and-treat approach in this vulnerable population - Teti, E; Selfridge, M; Perez Hernandez, F
American Association for the Study of Liver Diseases: The Liver Meeting; November 13–16, 2020; Accessed May 2, 2024 at: